Effects of Myo-inositol on Type 1 Retinopathy of Prematurity among Preterm Infants <28 Weeks' Gestational Age: A Randomized Clinical Trial

Dale L. Phelps, Kristi L. Watterberg, Tracy L. Nolen, Carol A. Cole, C. Michael Cotten, William Oh, Brenda B. Poindexter, Kristin M. Zaterka-Baxter, Abhik Das, Conra Backstrom Lacy, Ann Marie Scorsone, Michele C. Walsh, Edward F. Bell, Kathleen A. Kennedy, Kurt Schibler, Gregory M. Sokol, Matthew M. Laughon, Satyanarayana Lakshminrusimha, William E. Truog, Meena GargWaldemar A. Carlo, Abbot R. Laptook, Krisa P. Van Meurs, David P. Carlton, Amanda Graf, Sara B. Demauro, Luc P. Brion, Seetha Shankaran, Faruk H. Orge, Richard J. Olson, Helen Mintz-Hittner, Michael B. Yang, Kathryn M. Haider, David K. Wallace, Mina Chung, Denise Hug, Irena Tsui, Martin S. Cogen, John P. Donahue, Michael Gaynon, Amy K. Hutchinson, Don L. Bremer, Graham Quinn, Yu Guang He, William R. Lucas, Timothy W. Winter, Stephen D. Kicklighter, Kartik Kumar, Patricia R. Chess, Tarah T. Colaizy, Anna Marie Hibbs, Namasivayam Ambalavanan, Heidi M. Harmon, Elisabeth C. McGowan, Rosemary D. Higgins

Research output: Contribution to journal › Article › peer-review

27 Scopus citations

Effects of Myo-inositol on Type 1 Retinopathy of Prematurity among Preterm Infants <28 Weeks' Gestational Age: A Randomized Clinical Trial

Fingerprint

Medicine & Life Sciences